0001708138-21-000048.txt : 20210810 0001708138-21-000048.hdr.sgml : 20210810 20210810170559 ACCESSION NUMBER: 0001708138-21-000048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210806 FILED AS OF DATE: 20210810 DATE AS OF CHANGE: 20210810 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SCHLEIFER LEONARD S CENTRAL INDEX KEY: 0001218629 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 211160939 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-08-06 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001218629 SCHLEIFER LEONARD S 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 0 0 President & CEO Common Stock 2021-08-06 4 M 0 240000 52.03 A 573321 D Common Stock 2021-08-06 4 F 0 137145 607.51 D 436176 D Common Stock 2021-08-06 4 M 0 160000 52.03 A 596176 D Common Stock 2021-08-06 4 F 0 91430 607.51 D 504746 D Common Stock 2021-05-19 5 G 0 41178 0.0 A 41178 I By Trust Common Stock 2021-05-19 5 G 0 41178 0.0 D 0 I by 2019 GRAT Common Stock 200000 I 2021 GRAT Common Stock 5874 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 52.03 2021-08-06 4 M 0 240000 0.0 D 2021-12-16 Common Stock 240000 160000 D Non-Qualified Stock Option (right to buy) 52.03 2021-08-06 4 M 0 160000 0.0 D 2021-12-16 Common Stock 160000 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). These shares are held in a trust for the benefit of the reporting person's family members. The reporting person's spouse is a trustee of the trust. With respect to 240,000 underlying shares (of which 0 remain outstanding), the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014. With respect to 160,000 underlying shares (of which 0 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant. /s/**Leonard S. Schleifer 2021-08-10